±ÇÑʰ©ÊÇÖйúÄÏ·½³£¼ûµÄÍ·¾±Ö×Áö£¬£¬·¢²¡ÒԹ㶫×î¶à£¬£¬Òò´ËÒà³ÆÎª¡°¹ã¶«Áö¡±¡£¡£2017Äêngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÊÕÖεÄз¢±ÇÑʰ©²¡Àý´ï5609Àý¡£¡£Òź¶µÄÊÇ£¬£¬Áè¼Ý2/3µÄ±ÇÑʰ©»¼ÕßÔÚ¾ÍÕïʱÒѾ´¦ÓÚ¾Ö²¿ÇøÓòÍíÆÚ¡£¡£ÏÖÔÚÕⲿ·Ö»¼ÕßµÄÖÎÁÆ»ù±¾ÊÇͬÆÚ·Å»¯ÁÆ£¬£¬µ«ÈÔÓÐÔ¼20%µÄ»¼ÕßÔÚÖÎÁÆºó·ºÆðÔ¶´¦×ªÒÆ£¬£¬³ÉΪÖÎÁÆÊ§°ÜµÄÖ÷ÒªÔÒò¡£¡£

Âí¿¥½ÌÊÚÑо¿ÍŶÓ
ÓÉngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄǣͷ£¬£¬ÁªºÏÐÂ¼ÓÆÂ¹úÁ¢°©Ö¢ÖÐÐÄÒÔ¼°Ïã¸ÛÍþ¶û˹Ç×ÍõÒ½Ôº×é³É±ÇÑʰ©Ð×÷С×飬£¬¿ªÕ¹ÁËÒ»Ïî»ùÓÚÓÕµ¼»¯ÁÆËæ»ú±ÈÕÕÁÙ´²ÊÔÑé¸öÌåÊý¾ÝµÄ¹ú¼Ê¶àÖÐÐĺϲ¢ÆÊÎö£¬£¬ÔÚ¹ú¼ÊÉÏÊ×´ÎÈ·¶¨ÓÕµ¼»¯ÁƾßÓÐÈ·ÇÐÁÆÐ§¡£¡£Ñо¿Ð§¹ûÓÚ2ÔÂÔÚÏß½ÒÏþÓÚÈ«Çò¶¥¼¶Ö×ÁöרҵÔÓÖ¾¡¶Clinical Cancer Research¡·£¬£¬²¢±»Ñ¡Îªµ±ÆÚÁÁµãÎÄÕ£¨Highlights£©£¨2017ÄêÓ°ÏìÒò×Ó10.2·Ö£©¡£¡£
ÔçÔÚ2008Ä꣬£¬Õë¶Ô¾Ö²¿ÍíÆÚ±ÇÑʰ©£¬£¬ÃÀ¹úNCCNÖ¸ÄÏÆ¾Ö¤µÍ·¢ÇøµÄÁÙ´²ÊÔÑéЧ¹û£¬£¬ÍƼöͬÆÚ·Å»¯ÁÆÁªºÏ¸¨Öú»¯ÁÆÎª¾Ö²¿ÍíÆÚ±ÇÑʰ©µÄ±ê×¼ÖÎÁÆ·½°¸£¨1ÀàÍÆ¼ö£©¡£¡£Ôڸ߷¢Çø£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÂí¿¥½ÌÊڵĿÆÑÐÍŶÓÔÚ2012ÄêÍê³ÉÒ»Ïî¶àÖÐÐÄ3ÆÚÁÙ´²ÊÔÑ飬£¬ÔÚ¹ú¼ÊÉÏÊ×´Î֤ʵ¸¨Öú»¯ÁÆÎ´ÄܽøÒ»²½Ìá¸ßÁÆÐ§£¬£¬²¢ÇÒ´øÀ´ÏÔ×ŵÄÍÂÄæ¡¢¡¢¡¢ð¤Ä¤Ñ׵ȶ¾¸±·´Ó³£¨Lancet Oncol, 2012£©¡£¡£¸ÃÑо¿½ÒÏþÎôʱ¼´±»Å·ÖÞÖ¸ÄϽÓÄÉ£¬£¬´ÎÄ꣨2013Ä꣩±»ÃÀ¹úÖ¸ÄϽÓÄÉ¡£¡£
È»¶ø£¬£¬ÔõÑùÔÚͬÆÚ·Å»¯ÁƵĻù´¡ÉÏÌá¸ßÁÆÐ§ÉÐÐè½øÒ»²½Ñо¿¡£¡£Òò´Ë£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄÂí¿¥½ÌÊÚ¼°ËïÓ±½ÌÊÚÍŶÓÔÙ½ÓÔÙÀ÷£¬£¬ÔÙ´ÎÒÔÒ»Ïî¶àÖÐÐÄÈýÒ©ÓÕµ¼»¯ÁÆ£¨¶àÎ÷ËûÈü+˳²¬+5-·úÄòà×ण©Ëæ»ú±ÈÕÕÊÔÑ飬£¬ÔÚ¹ú¼ÊÉÏÊ×´Î֤ʵͬÆÚ·Å»¯ÁÆÇ°Ê¹ÓÃÓÕµ¼»¯ÁÆ¿ÉÏÔÖø½µµÍÔ¶´¦×ªÒÆÂʲ¢Ìá¸ß»¼ÕßÉúÑÄ£¨Lancet Oncol, 2016£©¡£¡£Óë´Ëͬʱ£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĺéÃ÷»Î½ÌÊÚÍŶÓÒà·¢Ã÷˳²¬+5-·úÄòà×à¤Á½Ò©ÓÕµ¼»¯ÁÆ·½°¸ÓÐDZÔÚÇ÷ÊÆ½µµÍÔ¶´¦×ªÒÆÂÊ£¨Eur J Cancer, 2017£©£»£»£»Ëæºó³ÂÃ÷Ô¶½ÌÊÚÍŶӽøÒ»²½Í¨¹ý¸ÃÁÙ´²ÊÔÑ齨ÉèÁË¿ÉÔ¤²âÓÕµ¼»¯ÁÆÁÆÐ§µÄ·Ö×ÓÄ£×Ó£¨Clin Cancer Res, 2017; Highlights£©¡£¡£
ΪÁË×îÖÕÃ÷È·ÓÕµ¼»¯ÁÆÔÚ¾Ö²¿ÍíÆÚ±ÇÑʰ©ÖеÄְ룬£¬ÓÉÂí¿¥½ÌÊÚ¡¢¡¢¡¢ºéÃ÷»Î½ÌÊÚǣͷ£¬£¬ÁªºÏÐÂ¼ÓÆÂ¼°Ïã¸ÛµÄÑо¿Õß¶Ô±ÇÑʰ©Ê¢ÐеØÇøµÄ1,193Àý»¼Õß¾ÙÐÐÁ˸öÌåÊý¾ÝºÏ²¢ÆÊÎö£¬£¬·¢Ã÷Ïà¹ØÓÚ´¿´âͬÆÚ·Å»¯ÁÆ£¬£¬ÓÕµ¼»¯ÁÆÁªÌõÔ¼ÆÚ·Å»¯Áƿɽ«»¼ÕßµÄ5ÄêÔ¶´¦×ªÒÆÂʽµµÍ7%£¬£¬5Äê×ÜÉúÑÄÂÊÌá¸ß6%£¬£¬Ã÷È·ÁËÓÕµ¼»¯ÁÆ¿Éͨ¹ý½µµÍ¾Ö²¿ÇøÓòÍíÆÚ±ÇÑʰ©µÄԶת·çÏÕ¶ø×ª»¯ÎªÉúÑÄ»ñÒæ£¬£¬È·¶¨ÁËÓÕµ¼»¯ÁÆÔÚ±ÇÑʰ©ÖÎÁÆÖеÄְλ¡£¡£
»ùÓÚÒÔÉÏÑо¿Ð§¹û£¬£¬2018Ä꣬£¬ÃÀ¹ú×îаæÖ¸ÄÏÒѽ«ÓÕµ¼»¯ÁÆ·½°¸´Ó³ÖÐø8ÄêµÄ3¼¶Ö¤¾ÝÉÏÉýÖÁ2A¼¶Ö¤¾Ý¡£¡£ÍâÑóÖøÃûýÌåbeforeitsnewsµÈÒÔ¡¶±ÇÑʰ©×ÛºÏÖÎÁÆÀï³Ì±®£ºÀ´×ÔÖйúѧÕßµÄ×îÐÂÑо¿Ï£Íû¡·£¨Milestones in Chemoradiotherapy Strategy for Nasopharyngeal Carcinoma: Recent Advances by Physicians Mainly from China£©ÎªÌâ¶ÔÂí¿¥½ÌÊÚµÈϵÁÐÑо¿¾ÙÐÐÁ˱¨µÀ¡£¡£
ÒÑÍùÊ®Ä꣬£¬¹ØÓÚ¾Ö²¿ÍíÆÚ±ÇÑʰ©µÄÖÎÁÆ£¬£¬ÃÀ¹úÖ¸ÄÏÆ¾Ö¤ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĵÄÔ´´ÐÔÑо¿×ö¹ýÁ½´ÎÖØ´óµ÷½â£º½µµÍ¸¨Öú»¯ÁƼ°Ìá¸ßÓÕµ¼»¯ÁƵÄÍÆ¼ö¡£¡£ÒԺ󣬣¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄѧÕß½«¼ÌÐø²»Î·¼èÐÁ£¬£¬ÇóË÷²»Ö¹£¬£¬ÔÚ»ù´¡ºÍÁÙ´²Ñо¿·½Ãæ²½²½Ç°ÐУ¬£¬Íƶ¯±ÇÑʰ©ÁÙ´²ÕïÁÆÔÚ¸öÌ廯¾«×¼ÕïÁÆÊ±´úµÄÒ»Ö±Í»ÆÆ£¬£¬Ô츣¿í´ó»¼Õß¡£¡£
ÔÎÄÁ´½Ó£ºhttp://clincancerres.aacrjournals.org/content/24/8/1824.long